{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:41:14Z","timestamp":1789072874418,"version":"build-2803163510"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institutes of Health, Neurological Diseases and Stroke","award":["R01NS121038"],"award-info":[{"award-number":["R01NS121038"]}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["HT9425-23-1-0337"],"award-info":[{"award-number":["HT9425-23-1-0337"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04861-x","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:49:13Z","timestamp":1767955753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human pluripotent stem cell models of Friedreich\u2019s ataxia: innovations, considerations, and future perspectives"],"prefix":"10.1186","volume":"17","author":[{"given":"Ha Thi","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Napierala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Napierala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"5254","key":"4861_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, et al. Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271(5254):1423\u20137.","journal-title":"Science"},{"issue":"16","key":"4861_CR2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, et al. Clinical and genetic abnormalities in patients with friedreich\u2019s ataxia. N Engl J Med. 1996;335(16):1169\u201375.","journal-title":"N Engl J Med"},{"issue":"3","key":"4861_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/104.3.589","volume":"104","author":"AE Harding","year":"1981","unstructured":"Harding AE. Friedreich\u2019s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 1981;104(3):589\u2013620.","journal-title":"Brain"},{"issue":"1\u20132","key":"4861_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","volume":"303","author":"AH Koeppen","year":"2011","unstructured":"Koeppen AH. Friedreich\u2019s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303(1\u20132):1\u201312.","journal-title":"J Neurol Sci"},{"issue":"5","key":"4861_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.celrep.2016.06.075","volume":"16","author":"J Gerhardt","year":"2016","unstructured":"Gerhardt J, Bhalla AD, Butler JS, Puckett JW, Dervan PB, Rosenwaks Z, et al. Stalled DNA replication forks at the endogenous GAA repeats drive repeat expansion in friedreich\u2019s ataxia cells. Cell Rep. 2016;16(5):1218\u201327.","journal-title":"Cell Rep"},{"issue":"1","key":"4861_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1086\/301680","volume":"62","author":"SI Bidichandani","year":"1998","unstructured":"Bidichandani SI, Ashizawa T, Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and May be associated with an unusual DNA structure. Am J Hum Genet. 1998;62(1):111\u201321.","journal-title":"Am J Hum Genet"},{"issue":"29","key":"4861_CR7","doi-asserted-by":"publisher","first-page":"27171","DOI":"10.1074\/jbc.M101879200","volume":"276","author":"N Sakamoto","year":"2001","unstructured":"Sakamoto N, Ohshima K, Montermini L, Pandolfo M, Wells RD, Sticky DNA. A self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J Biol Chem. 2001;276(29):27171\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"4861_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U","volume":"45","author":"M Cossee","year":"1999","unstructured":"Cossee M, Durr A, Schmitt M, Dahl N, Trouillas P, Allinson P, et al. Friedreich\u2019s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol. 1999;45(2):200\u20136.","journal-title":"Ann Neurol"},{"issue":"6","key":"4861_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1388-2457(00)00290-X","volume":"111","author":"L Santoro","year":"2000","unstructured":"Santoro L, Perretti A, Lanzillo B, Coppola G, De Joanna G, Manganelli F, et al. Influence of GAA expansion size and disease duration on central nervous system impairment in friedreich\u2019s ataxia: contribution to the Understanding of the pathophysiology of the disease. Clin Neurophysiol. 2000;111(6):1023\u201330.","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"4861_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A Rotig","year":"1997","unstructured":"Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215\u20137.","journal-title":"Nat Genet"},{"issue":"R1","key":"4861_CR11","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1093\/hmg\/ddq165","volume":"19","author":"S Schmucker","year":"2010","unstructured":"Schmucker S, Puccio H. Understanding the molecular mechanisms of friedreich\u2019s ataxia to develop therapeutic approaches. Hum Mol Genet. 2010;19(R1):R103\u2013110.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"4861_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/dmm.009019","volume":"5","author":"TA Rouault","year":"2012","unstructured":"Rouault TA. Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. Dis Model Mech. 2012;5(2):155\u201364.","journal-title":"Dis Model Mech"},{"issue":"8","key":"4861_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/hmg\/9.8.1219","volume":"9","author":"M Cossee","year":"2000","unstructured":"Cossee M, Puccio H, Gansmuller A, Koutnikova H, Dierich A, LeMeur M, et al. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet. 2000;9(8):1219\u201326.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4861_CR14","doi-asserted-by":"publisher","first-page":"e200236","DOI":"10.1212\/NXG.0000000000200236","volume":"11","author":"M Pandolfo","year":"2025","unstructured":"Pandolfo M. Friedreich ataxia: an (Almost) 30-Year history after gene discovery. Neurol Genet. 2025;11(1):e200236.","journal-title":"Neurol Genet"},{"issue":"4","key":"4861_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-025-01065-y","volume":"21","author":"E Indelicato","year":"2025","unstructured":"Indelicato E, Delatycki MB, Farmer J, Franca MC Jr., Perlman S, Rai M, et al. A global perspective on research advances and future challenges in Friedreich ataxia. Nat Rev Neurol. 2025;21(4):204\u201315.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"4861_CR16","doi-asserted-by":"publisher","first-page":"119809","DOI":"10.1016\/j.bbamcr.2024.119809","volume":"1871","author":"V Mosbach","year":"2024","unstructured":"Mosbach V, Puccio H. A multiple animal and cellular models approach to study frataxin deficiency in Friedreich ataxia. Biochim Biophys Acta Mol Cell Res. 2024;1871(7):119809.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4861_CR17","doi-asserted-by":"crossref","unstructured":"Nair DG, Weiskirchen R. Advanced in vitro models for preclinical drug safety: recent progress and prospects. Curr Issues Mol Biol. 2024; 47(1).","DOI":"10.3390\/cimb47010007"},{"key":"4861_CR18","doi-asserted-by":"crossref","unstructured":"Zushin PH, Mukherjee S, Wu JC. FDA modernization act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest. 2023; 133(21).","DOI":"10.1172\/JCI175824"},{"issue":"1","key":"4861_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-023-00376-8","volume":"12","author":"S Maheshwari","year":"2023","unstructured":"Maheshwari S, Vilema-Enriquez G, Wade-Martins R. Patient-derived iPSC models of Friedreich ataxia: a new frontier for Understanding disease mechanisms and therapeutic application. Transl Neurodegener. 2023;12(1):45.","journal-title":"Transl Neurodegener"},{"key":"4861_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145\u20137.","journal-title":"Science"},{"issue":"5","key":"4861_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3109\/07853890.2015.1051579","volume":"47","author":"OE Simonson","year":"2015","unstructured":"Simonson OE, Domogatskaya A, Volchkov P, Rodin S. The safety of human pluripotent stem cells in clinical treatment. Ann Med. 2015;47(5):370\u201380.","journal-title":"Ann Med"},{"issue":"6","key":"4861_CR22","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.stemcr.2021.05.012","volume":"16","author":"R Lovell-Badge","year":"2021","unstructured":"Lovell-Badge R, Anthony E, Barker RA, Bubela T, Brivanlou AH, Carpenter M, et al. ISSCR guidelines for stem cell research and clinical translation: the 2021 update. Stem Cell Rep. 2021;16(6):1398\u2013408.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"4861_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"5","key":"4861_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"key":"4861_CR25","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u201320.","journal-title":"Science"},{"issue":"1","key":"4861_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nbt1374","volume":"26","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26(1):101\u20136.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"4861_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nbt.1502","volume":"26","author":"D Huangfu","year":"2008","unstructured":"Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26(11):1269\u201375.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"4861_CR28","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/cells10061470","volume":"10","author":"G Scesa","year":"2021","unstructured":"Scesa G, Adami R, Bottai D. iPSC Preparation and epigenetic memory: does the tissue origin matter? Cells. 2021;10(6):1470.","journal-title":"Cells"},{"key":"4861_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.gene.2018.11.069","volume":"686","author":"KK Haridhasapavalan","year":"2019","unstructured":"Haridhasapavalan KK, Borgohain MP, Dey C, Saha B, Narayan G, Kumar S, et al. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. Gene. 2019;686:146\u201359.","journal-title":"Gene"},{"key":"4861_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-1-0716-1084-8_9","volume":"2239","author":"F Febbraro","year":"2021","unstructured":"Febbraro F, Chen M, Denham M. Generation of human iPSCs by episomal reprogramming of skin fibroblasts and peripheral blood mononuclear cells. Methods Mol Biol. 2021;2239:135\u201351.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"4861_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13287-018-0908-z","volume":"9","author":"H Gu","year":"2018","unstructured":"Gu H, Huang X, Xu J, Song L, Liu S, Zhang XB, et al. Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood. Stem Cell Res Ther. 2018;9(1):163.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4861_CR32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618\u201330.","journal-title":"Cell Stem Cell"},{"issue":"7909","key":"4861_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-022-04593-5","volume":"605","author":"J Guan","year":"2022","unstructured":"Guan J, Wang G, Wang J, Zhang Z, Fu Y, Cheng L, et al. Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature. 2022;605(7909):325\u201331.","journal-title":"Nature"},{"issue":"7","key":"4861_CR34","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41589-024-01799-8","volume":"21","author":"Y Wang","year":"2025","unstructured":"Wang Y, Peng F, Yang Z, Cheng L, Cao J, Fu X, et al. A rapid chemical reprogramming system to generate human pluripotent stem cells. Nat Chem Biol. 2025;21(7):1030\u20138.","journal-title":"Nat Chem Biol"},{"issue":"33","key":"4861_CR35","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehs203","volume":"34","author":"K Streckfuss-Bomeke","year":"2013","unstructured":"Streckfuss-Bomeke K, Wolf F, Azizian A, Stauske M, Tiburcy M, Wagner S, et al. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J. 2013;34(33):2618\u201329.","journal-title":"Eur Heart J"},{"issue":"1","key":"4861_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.stem.2010.06.002","volume":"7","author":"J Staerk","year":"2010","unstructured":"Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell. 2010;7(1):20\u20134.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4861_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.stem.2009.06.008","volume":"5","author":"MH Chin","year":"2009","unstructured":"Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009;5(1):111\u201323.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"4861_CR38","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ng.471","volume":"41","author":"A Doi","year":"2009","unstructured":"Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue- and cancer-specific CpG Island Shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41(12):1350\u20133.","journal-title":"Nat Genet"},{"issue":"7313","key":"4861_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285\u201390.","journal-title":"Nature"},{"issue":"1","key":"4861_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2011.06.007","volume":"9","author":"O Bar-Nur","year":"2011","unstructured":"Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and Preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 2011;9(1):17\u201323.","journal-title":"Cell Stem Cell"},{"issue":"16","key":"4861_CR41","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.3390\/ijms21165705","volume":"21","author":"P Chlebanowska","year":"2020","unstructured":"Chlebanowska P, Sulkowski M, Skrzypek K, Tejchman A, Muszynska A, Noroozi R, et al. Origin of the induced pluripotent stem cells affects their differentiation into dopaminergic neurons. Int J Mol Sci. 2020;21(16):5705.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4861_CR42","doi-asserted-by":"publisher","first-page":"118538","DOI":"10.1016\/j.bbamcr.2019.118538","volume":"1867","author":"E Pianezzi","year":"2020","unstructured":"Pianezzi E, Altomare C, Bolis S, Balbi C, Torre T, Rinaldi A, et al. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes. Biochim Biophys Acta Mol Cell Res. 2020;1867(3):118538.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"4861_CR43","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/s41467-025-56569-4","volume":"16","author":"K Quaid","year":"2025","unstructured":"Quaid K, Xing X, Chen YH, Miao Y, Neilson A, Selvamani V, et al. iPSCs and iPSC-derived cells as a model of human genetic and epigenetic variation. Nat Commun. 2025;16(1):1750.","journal-title":"Nat Commun"},{"key":"4861_CR44","doi-asserted-by":"crossref","unstructured":"Hu S, Zhao MT, Jahanbani F, Shao NY, Lee WH, Chen H et al. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. JCI Insight. 2016; 1(8).","DOI":"10.1172\/jci.insight.85558"},{"issue":"12","key":"4861_CR45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/nbt.2051","volume":"29","author":"IS Cell","year":"2011","unstructured":"Cell IS, Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29(12):1132\u201344.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"4861_CR46","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.stem.2022.11.006","volume":"29","author":"PW Andrews","year":"2022","unstructured":"Andrews PW, Barbaric I, Benvenisty N, Draper JS, Ludwig T, Merkle FT, et al. The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells. Cell Stem Cell. 2022;29(12):1624\u201336.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"4861_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/molehr\/gat077","volume":"20","author":"HT Nguyen","year":"2014","unstructured":"Nguyen HT, Geens M, Mertzanidou A, Jacobs K, Heirman C, Breckpot K, et al. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL. Mol Hum Reprod. 2014;20(2):168\u201377.","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"4861_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.stemcr.2013.10.005","volume":"1","author":"S Avery","year":"2013","unstructured":"Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep. 2013;1(5):379\u201386.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"4861_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.stemcr.2019.05.005","volume":"13","author":"C Markouli","year":"2019","unstructured":"Markouli C, Couvreu De Deckersberg E, Regin M, Nguyen HT, Zambelli F, Keller A, et al. Gain of 20q11.21 in human pluripotent stem cells impairs TGF-beta-Dependent neuroectodermal commitment. Stem Cell Rep. 2019;13(1):163\u201376.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"4861_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.stemcr.2024.03.001","volume":"19","author":"Y Lei","year":"2024","unstructured":"Lei Y, Al Delbany D, Krivec N, Regin M, Couvreu de Deckersberg E, Janssens C, et al. SALL3 mediates the loss of neuroectodermal differentiation potential in human embryonic stem cells with chromosome 18q loss. Stem Cell Rep. 2024;19(4):562\u201378.","journal-title":"Stem Cell Rep"},{"key":"4861_CR51","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/ncomms5825","volume":"5","author":"U Ben-David","year":"2014","unstructured":"Ben-David U, Arad G, Weissbein U, Mandefro B, Maimon A, Golan-Lev T, et al. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells. Nat Commun. 2014;5:4825.","journal-title":"Nat Commun"},{"issue":"2","key":"4861_CR52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/humupd\/dms048","volume":"19","author":"HT Nguyen","year":"2013","unstructured":"Nguyen HT, Geens M, Spits C. Genetic and epigenetic instability in human pluripotent stem cells. Hum Reprod Update. 2013;19(2):187\u2013205.","journal-title":"Hum Reprod Update"},{"key":"4861_CR53","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/ncomms5227","volume":"5","author":"K Jacobs","year":"2014","unstructured":"Jacobs K, Mertzanidou A, Geens M, Nguyen HT, Staessen C, Spits C. Low-grade chromosomal mosaicism in human somatic and embryonic stem cell populations. Nat Commun. 2014;5:4227.","journal-title":"Nat Commun"},{"issue":"10","key":"4861_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrg3271","volume":"13","author":"RJ Lund","year":"2012","unstructured":"Lund RJ, Narva E, Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet. 2012;13(10):732\u201344.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"4861_CR55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1089\/scd.2014.0292","volume":"24","author":"Q Bai","year":"2015","unstructured":"Bai Q, Ramirez JM, Becker F, Pantesco V, Lavabre-Bertrand T, Hovatta O, et al. Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells. Stem Cells Dev. 2015;24(5):653\u201362.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4861_CR56","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/s41467-020-15271-3","volume":"11","author":"O Thompson","year":"2020","unstructured":"Thompson O, von Meyenn F, Hewitt Z, Alexander J, Wood A, Weightman R, et al. Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions. Nat Commun. 2020;11(1):1528.","journal-title":"Nat Commun"},{"issue":"3","key":"4861_CR57","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.stemcr.2016.01.015","volume":"6","author":"K Jacobs","year":"2016","unstructured":"Jacobs K, Zambelli F, Mertzanidou A, Smolders I, Geens M, Nguyen HT, et al. Higher-Density culture in human embryonic stem cells results in DNA damage and genome instability. Stem Cell Rep. 2016;6(3):330\u201341.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"4861_CR58","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1038\/s41467-024-49335-5","volume":"15","author":"R Araki","year":"2024","unstructured":"Araki R, Suga T, Hoki Y, Imadome K, Sunayama M, Kamimura S, et al. iPS cell generation-associated point mutations include many C\u2009>\u2009T substitutions via different cytosine modification mechanisms. Nat Commun. 2024;15(1):4946.","journal-title":"Nat Commun"},{"issue":"2","key":"4861_CR59","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.celrep.2017.09.060","volume":"21","author":"M Yoshihara","year":"2017","unstructured":"Yoshihara M, Araki R, Kasama Y, Sunayama M, Abe M, Nishida K, et al. Hotspots of de Novo point mutations in induced pluripotent stem cells. Cell Rep. 2017;21(2):308\u201315.","journal-title":"Cell Rep"},{"key":"4861_CR60","unstructured":"ISSCR. Standards for human stem cell use in research; 2023."},{"key":"4861_CR61","doi-asserted-by":"crossref","unstructured":"Lim PSL, Meshorer E. Organization of the pluripotent genome. Cold Spring Harb Perspect Biol. 2021; 13(2).","DOI":"10.1101\/cshperspect.a040204"},{"issue":"2","key":"4861_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315\u201326.","journal-title":"Cell"},{"issue":"1","key":"4861_CR63","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41467-024-45506-6","volume":"15","author":"TD Arthur","year":"2024","unstructured":"Arthur TD, Nguyen JP, D\u2019Antonio-Chronowska A, Matsui H, Silva NS, Joshua IN, et al. Complex regulatory networks influence pluripotent cell state transitions in human iPSCs. Nat Commun. 2024;15(1):1664.","journal-title":"Nat Commun"},{"issue":"1","key":"4861_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A Bird","year":"2002","unstructured":"Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6\u201321.","journal-title":"Genes Dev"},{"issue":"2","key":"4861_CR65","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","volume":"6","author":"A Kyttala","year":"2016","unstructured":"Kyttala A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy KK, et al. Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential. Stem Cell Rep. 2016;6(2):200\u201312.","journal-title":"Stem Cell Rep"},{"issue":"7658","key":"4861_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature. 2017;546(7658):370\u20135.","journal-title":"Nature"},{"issue":"4","key":"4861_CR67","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stem.2016.11.005","volume":"20","author":"I Carcamo-Orive","year":"2017","unstructured":"Carcamo-Orive I, Hoffman GE, Cundiff P, Beckmann ND, D\u2019Souza SL, Knowles JW, et al. Analysis of transcriptional variability in a large human iPSC library reveals genetic and Non-genetic determinants of heterogeneity. Cell Stem Cell. 2017;20(4):518\u2013e532519.","journal-title":"Cell Stem Cell"},{"key":"4861_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-biochem-103019-102815","volume":"89","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhang Y. Role of mammalian DNA methyltransferases in development. Annu Rev Biochem. 2020;89:135\u201358.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"4861_CR69","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.cell.2013.04.022","volume":"153","author":"W Xie","year":"2013","unstructured":"Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 2013;153(5):1134\u201348.","journal-title":"Cell"},{"issue":"Pt 17","key":"4861_CR70","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1242\/jcs.02500","volume":"118","author":"AE Wiblin","year":"2005","unstructured":"Wiblin AE, Cui W, Clark AJ, Bickmore WA. Distinctive nuclear organisation of centromeres and regions involved in pluripotency in human embryonic stem cells. J Cell Sci. 2005;118(Pt 17):3861\u20138.","journal-title":"J Cell Sci"},{"issue":"7398","key":"4861_CR71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485(7398):376\u201380.","journal-title":"Nature"},{"issue":"7466","key":"4861_CR72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature12420","volume":"501","author":"E de Wit","year":"2013","unstructured":"de Wit E, Bouwman BA, Zhu Y, Klous P, Splinter E, Verstegen MJ, et al. The pluripotent genome in three dimensions is shaped around pluripotency factors. Nature. 2013;501(7466):227\u201331.","journal-title":"Nature"},{"issue":"7539","key":"4861_CR73","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature14222","volume":"518","author":"JR Dixon","year":"2015","unstructured":"Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, et al. Chromatin architecture reorganization during stem cell differentiation. Nature. 2015;518(7539):331\u20136.","journal-title":"Nature"},{"issue":"1","key":"4861_CR74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13059-023-02849-5","volume":"24","author":"PP Shah","year":"2023","unstructured":"Shah PP, Keough KC, Gjoni K, Santini GT, Abdill RJ, Wickramasinghe NM, et al. An atlas of lamina-associated chromatin across twelve human cell types reveals an intermediate chromatin subtype. Genome Biol. 2023;24(1):16.","journal-title":"Genome Biol"},{"key":"4861_CR75","doi-asserted-by":"crossref","unstructured":"Finn EH, Misteli T. Molecular basis and biological function of variability in Spatial genome organization. Science. 2019; 365(6457).","DOI":"10.1126\/science.aaw9498"},{"issue":"2","key":"4861_CR76","first-page":"460","volume":"60","author":"L Pianese","year":"1997","unstructured":"Pianese L, Cavalcanti F, De Michele G, Filla A, Campanella G, Calabrese O, et al. The effect of parental gender on the GAA dynamic mutation in the FRDA gene. Am J Hum Genet. 1997;60(2):460\u20133.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"4861_CR77","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/jmg.35.9.713","volume":"35","author":"MB Delatycki","year":"1998","unstructured":"Delatycki MB, Paris D, Gardner RJM, Forshaw K, Nicholson GA, Nassif N, et al. Sperm DNA analysis in a Friedreich ataxia premutation carrier suggests both meiotic and mitotic expansion in the FRDA gene. J Med Genet. 1998;35(9):713\u20136.","journal-title":"J Med Genet"},{"issue":"3","key":"4861_CR78","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.stem.2022.01.014","volume":"29","author":"J Taubenschmid-Stowers","year":"2022","unstructured":"Taubenschmid-Stowers J, Rostovskaya M, Santos F, Ljung S, Argelaguet R, Krueger F, et al. 8\u00a0C-like cells capture the human zygotic genome activation program in vitro. Cell Stem Cell. 2022;29(3):449\u2013e459446.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4861_CR79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41467-023-43871-2","volume":"15","author":"SN Esfahani","year":"2024","unstructured":"Esfahani SN, Zheng Y, Arabpour A, Irizarry AMR, Kobayashi N, Xue X, et al. Derivation of human primordial germ cell-like cells in an embryonic-like culture. Nat Commun. 2024;15(1):167.","journal-title":"Nat Commun"},{"issue":"5","key":"4861_CR80","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.stem.2010.09.014","volume":"7","author":"S Ku","year":"2010","unstructured":"Ku S, Soragni E, Campau E, Thomas EA, Altun G, Laurent LC, et al. Friedreich\u2019s ataxia induced pluripotent stem cells model intergenerational GAA\u22c5TTC triplet repeat instability. Cell Stem Cell. 2010;7(5):631\u20137.","journal-title":"Cell Stem Cell"},{"issue":"35","key":"4861_CR81","doi-asserted-by":"publisher","first-page":"29861","DOI":"10.1074\/jbc.M112.391961","volume":"287","author":"J Du","year":"2012","unstructured":"Du J, Campau E, Soragni E, Ku S, Puckett JW, Dervan PB, et al. Role of mismatch repair enzymes in GAA.TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells. J Biol Chem. 2012;287(35):29861\u201372.","journal-title":"J Biol Chem"},{"issue":"3","key":"4861_CR82","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12015-010-9210-x","volume":"7","author":"J Liu","year":"2011","unstructured":"Liu J, Verma PJ, Evans-Galea MV, Delatycki MB, Michalska A, Leung J, et al. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev Rep. 2011;7(3):703\u201313.","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"4861_CR83","first-page":"608","volume":"6","author":"A Hick","year":"2013","unstructured":"Hick A, Wattenhofer-Donze M, Chintawar S, Tropel P, Simard JP, Vaucamps N, et al. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in friedreich\u2019s ataxia. Dis Model Mech. 2013;6(3):608\u201321.","journal-title":"Dis Model Mech"},{"issue":"23","key":"4861_CR84","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1089\/scd.2016.0147","volume":"25","author":"U Polak","year":"2016","unstructured":"Polak U, Li Y, Butler JS, Napierala M. Alleviating GAA repeat induced transcriptional Silencing of the friedreich\u2019s ataxia gene during somatic cell reprogramming. Stem Cells Dev. 2016;25(23):1788\u2013800.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4861_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13072-025-00588-4","volume":"18","author":"J Grant-Bier","year":"2025","unstructured":"Grant-Bier J, Ruppert K, Hayward B, Usdin K, Kumari D. MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome or the FXN locus in friedreich\u2019s ataxia. Epigenetics Chromatin. 2025;18(1):24.","journal-title":"Epigenetics Chromatin"},{"issue":"2","key":"4861_CR86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/21678707.2019.1562334","volume":"7","author":"AM Schreiber","year":"2019","unstructured":"Schreiber AM, Misiorek JO, Napierala JS, Napierala M. Progress in Understanding friedreich\u2019s ataxia using human induced pluripotent stem cells. Expert Opin Orphan Drugs. 2019;7(2):81\u201390.","journal-title":"Expert Opin Orphan Drugs"},{"key":"4861_CR87","doi-asserted-by":"publisher","first-page":"RP92025","DOI":"10.7554\/eLife.92025.3","volume":"13","author":"AJ Brenes","year":"2024","unstructured":"Brenes AJ, Griesser E, Sinclair LV, Davidson L, Prescott AR, Singh F, et al. Proteomic and functional comparison between human induced and embryonic stem cells. Elife. 2024;13:RP92025.","journal-title":"Elife"},{"issue":"Suppl 1","key":"4861_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","volume":"256","author":"M Pandolfo","year":"2009","unstructured":"Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(Suppl 1):3\u20138.","journal-title":"J Neurol"},{"issue":"2","key":"4861_CR89","first-page":"101","volume":"76","author":"AH Koeppen","year":"2017","unstructured":"Koeppen AH, Becker AB, Qian J, Feustel PJ. Friedreich ataxia: hypoplasia of spinal cord and dorsal root ganglia. J Neuropathol Exp Neurol. 2017;76(2):101\u20138.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"22","key":"4861_CR90","first-page":"4847","volume":"25","author":"F Codazzi","year":"2016","unstructured":"Codazzi F, Hu A, Rai M, Donatello S, Salerno Scarzella F, et al. Friedreich ataxia-induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor. Hum Mol Genet. 2016;25(22):4847\u201355.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4861_CR91","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1038\/s41467-020-17954-3","volume":"11","author":"PG Mazzara","year":"2020","unstructured":"Mazzara PG, Muggeo S, Luoni M, Massimino L, Zaghi M, Valverde PT, et al. Frataxin gene editing rescues friedreich\u2019s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons. Nat Commun. 2020;11(1):4178.","journal-title":"Nat Commun"},{"issue":"1","key":"4861_CR92","doi-asserted-by":"publisher","first-page":"fcad007","DOI":"10.1093\/braincomms\/fcad007","volume":"5","author":"C Dionisi","year":"2023","unstructured":"Dionisi C, Chazalon M, Rai M, Keime C, Imbault V, Communi D, et al. Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties. Brain Commun. 2023;5(1):fcad007.","journal-title":"Brain Commun"},{"key":"4861_CR93","doi-asserted-by":"publisher","first-page":"1323491","DOI":"10.3389\/fphar.2024.1323491","volume":"15","author":"P Mishra","year":"2024","unstructured":"Mishra P, Sivakumar A, Johnson A, Pernaci C, Warden AS, El-Hachem LR, et al. Gene editing improves Endoplasmic reticulum-mitochondrial contacts and unfolded protein response in friedreich\u2019s ataxia iPSC-derived neurons. Front Pharmacol. 2024;15:1323491.","journal-title":"Front Pharmacol"},{"key":"4861_CR94","doi-asserted-by":"publisher","first-page":"103477","DOI":"10.1016\/j.scr.2024.103477","volume":"79","author":"S Miellet","year":"2024","unstructured":"Miellet S, Maddock M, Napierala JS, Napierala M, Dottori M. Generation of genetically modified friedreich\u2019s ataxia induced pluripotent stem cell lines and isogenic control lines carrying an inducible neurogenin-2 expression cassette. Stem Cell Res. 2024;79:103477.","journal-title":"Stem Cell Res"},{"key":"4861_CR95","doi-asserted-by":"publisher","first-page":"600895","DOI":"10.3389\/fncel.2020.600895","volume":"14","author":"AJ Hulme","year":"2020","unstructured":"Hulme AJ, McArthur JR, Maksour S, Miellet S, Ooi L, Adams DJ, et al. Molecular and functional characterization of Neurogenin-2 induced human sensory neurons. Front Cell Neurosci. 2020;14:600895.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"4861_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.stemcr.2021.11.015","volume":"17","author":"AJ Hulme","year":"2022","unstructured":"Hulme AJ, Maksour S, St-Clair Glover M, Miellet S, Dottori M. Making neurons, made easy: the use of Neurogenin-2 in neuronal differentiation. Stem Cell Rep. 2022;17(1):14\u201334.","journal-title":"Stem Cell Rep"},{"issue":"11","key":"4861_CR97","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","volume":"72","author":"F Pousset","year":"2015","unstructured":"Pousset F, Legrand L, Monin ML, Ewenczyk C, Charles P, Komajda M, et al. A 22-Year Follow-up study of Long-term cardiac outcome and predictors of survival in Friedreich ataxia. JAMA Neurol. 2015;72(11):1334\u201341.","journal-title":"JAMA Neurol"},{"issue":"9","key":"4861_CR98","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00424-013-1414-x","volume":"466","author":"YK Lee","year":"2014","unstructured":"Lee YK, Ho PW, Schick R, Lau YM, Lai WH, Zhou T, et al. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Pflugers Arch. 2014;466(9):1831\u201344.","journal-title":"Pflugers Arch"},{"key":"4861_CR99","doi-asserted-by":"crossref","unstructured":"Bolotta A, Abruzzo PM, Baldassarro VA, Ghezzo A, Scotlandi K, Marini M et al. New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich\u2019s Ataxia Patient. Oxid Med Cell Longev. 2019; 2019:7623023.","DOI":"10.1155\/2019\/7623023"},{"issue":"5","key":"4861_CR100","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.18632\/aging.101247","volume":"9","author":"DE Crombie","year":"2017","unstructured":"Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, et al. Friedreich\u2019s ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency. Aging. 2017;9(5):1440\u201352.","journal-title":"Aging"},{"key":"4861_CR101","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.scr.2019.101529","volume":"40","author":"J Li","year":"2019","unstructured":"Li J, Rozwadowska N, Clark A, Fil D, Napierala JS, Napierala M. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived friedreich\u2019s ataxia cardiomyocytes. Stem Cell Res. 2019;40:101529.","journal-title":"Stem Cell Res"},{"issue":"1","key":"4861_CR102","doi-asserted-by":"publisher","first-page":"e2093","DOI":"10.1002\/mgg3.2093","volume":"11","author":"MB Angulo","year":"2023","unstructured":"Angulo MB, Bertalovitz A, Argenziano MA, Yang J, Patel A, Zesiewicz T, et al. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes. Mol Genet Genomic Med. 2023;11(1):e2093.","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"4861_CR103","doi-asserted-by":"publisher","first-page":"dmm049497","DOI":"10.1242\/dmm.049497","volume":"16","author":"MG Cotticelli","year":"2023","unstructured":"Cotticelli MG, Xia S, Truitt R, Doliba NM, Rozo AV, Tobias JW, et al. Acute frataxin knockdown in induced pluripotent stem cell-derived cardiomyocytes activates a type I interferon response. Dis Model Mech. 2023;16(5):dmm049497.","journal-title":"Dis Model Mech"},{"issue":"4","key":"4861_CR104","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.24260","volume":"76","author":"E Soragni","year":"2014","unstructured":"Soragni E, Miao W, Iudicello M, Jacoby D, De Mercanti S, Clerico M, et al. Epigenetic therapy for Friedreich ataxia. Ann Neurol. 2014;76(4):489\u2013508.","journal-title":"Ann Neurol"},{"key":"4861_CR105","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fneur.2015.00044","volume":"6","author":"E Soragni","year":"2015","unstructured":"Soragni E, Chou CJ, Rusche JR, Gottesfeld JM. Mechanism of action of 2-Aminobenzamide HDAC inhibitors in reversing gene Silencing in friedreich\u2019s ataxia. Front Neurol. 2015;6:44.","journal-title":"Front Neurol"},{"issue":"6","key":"4861_CR106","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1074\/jbc.RA118.006515","volume":"294","author":"JI Lai","year":"2019","unstructured":"Lai JI, Nachun D, Petrosyan L, Throesch B, Campau E, Gao F, et al. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures. J Biol Chem. 2019;294(6):1846\u201359.","journal-title":"J Biol Chem"},{"key":"4861_CR107","doi-asserted-by":"publisher","first-page":"836476","DOI":"10.3389\/fnins.2022.836476","volume":"16","author":"AM Schreiber","year":"2022","unstructured":"Schreiber AM, Li Y, Chen YH, Napierala JS, Napierala M. Selected histone deacetylase inhibitors reverse the frataxin transcriptional defect in a novel friedreich\u2019s ataxia induced pluripotent stem Cell-Derived neuronal reporter system. Front Neurosci. 2022;16:836476.","journal-title":"Front Neurosci"},{"issue":"1","key":"4861_CR108","doi-asserted-by":"publisher","first-page":"14568","DOI":"10.1038\/s41598-019-49870-y","volume":"9","author":"P Georges","year":"2019","unstructured":"Georges P, Boza-Moran MG, Gide J, Peche GA, Foret B, Bayot A, et al. Induced pluripotent stem cells-derived neurons from patients with Friedreich ataxia exhibit differential sensitivity to Resveratrol and nicotinamide. Sci Rep. 2019;9(1):14568.","journal-title":"Sci Rep"},{"issue":"6370","key":"4861_CR109","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1126\/science.aan6414","volume":"358","author":"GS Erwin","year":"2017","unstructured":"Erwin GS, Grieshop MP, Ali A, Qi J, Lawlor M, Kumar D, et al. Synthetic transcription elongation factors license transcription across repressive chromatin. Science. 2017;358(6370):1617\u201322.","journal-title":"Science"},{"issue":"9","key":"4861_CR110","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1261\/rna.071290.119","volume":"25","author":"X Shen","year":"2019","unstructured":"Shen X, Beasley S, Putman JN, Li Y, Prakash TP, Rigo F, et al. Efficient electroporation of neuronal cells using synthetic oligonucleotides: identifying duplex RNA and antisense oligonucleotide activators of human frataxin expression. RNA. 2019;25(9):1118\u201329.","journal-title":"RNA"},{"issue":"20","key":"4861_CR111","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1093\/nar\/gkab954","volume":"49","author":"Y Li","year":"2021","unstructured":"Li Y, Li J, Wang J, Lynch DR, Shen X, Corey DR, et al. Targeting 3\u2019 and 5\u2019 untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression. Nucleic Acids Res. 2021;49(20):11560\u201374.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4861_CR112","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/nat.2017.0703","volume":"28","author":"L Li","year":"2018","unstructured":"Li L, Shen X, Liu Z, Norrbom M, Prakash TP, O\u2019Reilly D, et al. Activation of frataxin protein expression by antisense oligonucleotides targeting the mutant expanded repeat. Nucleic Acid Ther. 2018;28(1):23\u201333.","journal-title":"Nucleic Acid Ther"},{"issue":"11","key":"4861_CR113","doi-asserted-by":"publisher","first-page":"115472","DOI":"10.1016\/j.bmc.2020.115472","volume":"28","author":"X Shen","year":"2020","unstructured":"Shen X, Wong J, Prakash TP, Rigo F, Li Y, Napierala M, et al. Progress towards drug discovery for friedreich\u2019s ataxia: identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein. Bioorg Med Chem. 2020;28(11):115472.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"4861_CR114","doi-asserted-by":"publisher","first-page":"e134221","DOI":"10.1172\/jci.insight.134221","volume":"5","author":"M Igoillo-Esteve","year":"2020","unstructured":"Igoillo-Esteve M, Oliveira AF, Cosentino C, Fantuzzi F, Demarez C, Toivonen S, et al. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia. JCI Insight. 2020;5(2):e134221.","journal-title":"JCI Insight"},{"key":"4861_CR115","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.redox.2020.101791","volume":"38","author":"P La Rosa","year":"2021","unstructured":"La Rosa P, Petrillo S, Turchi R, Berardinelli F, Schirinzi T, Vasco G, et al. The Nrf2 induction prevents ferroptosis in friedreich\u2019s ataxia. Redox Biol. 2021;38:101791.","journal-title":"Redox Biol"},{"issue":"4\u20136","key":"4861_CR116","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/ars.2024.0756","volume":"43","author":"W Yang","year":"2025","unstructured":"Yang W, Thompson B, Miellet S, Maddock M, Napierala M, Dottori M, et al. Sulforaphane targets multiple pathological processes in Friedreich ataxia Patient-Induced pluripotent stem Cell-Derived sensory neurons. Antioxid Redox Signal. 2025;43(4\u20136):308\u201327.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"4861_CR117","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","volume":"30","author":"F Pilotto","year":"2024","unstructured":"Pilotto F, Chellapandi DM, Puccio H. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia. Trends Mol Med. 2024;30(2):117\u201325.","journal-title":"Trends Mol Med"},{"key":"4861_CR118","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ijcard.2015.11.101","volume":"203","author":"YK Lee","year":"2016","unstructured":"Lee YK, Lau YM, Ng KM, Lai WH, Ho SL, Tse HF, et al. Efficient Attenuation of friedreich\u2019s ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Int J Cardiol. 2016;203:964\u201371.","journal-title":"Int J Cardiol"},{"issue":"6","key":"4861_CR119","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/mt.2015.41","volume":"23","author":"Y Li","year":"2015","unstructured":"Li Y, Polak U, Bhalla AD, Rozwadowska N, Butler JS, Lynch DR, et al. Excision of expanded GAA repeats alleviates the molecular phenotype of friedreich\u2019s ataxia. Mol Ther. 2015;23(6):1055\u201365.","journal-title":"Mol Ther"},{"issue":"7","key":"4861_CR120","doi-asserted-by":"publisher","first-page":"e22001","DOI":"10.1371\/journal.pone.0022001","volume":"6","author":"N Puspasari","year":"2011","unstructured":"Puspasari N, Rowley SM, Gordon L, Lockhart PJ, Ioannou PA, Delatycki MB, et al. Long range regulation of human FXN gene expression. PLoS ONE. 2011;6(7):e22001.","journal-title":"PLoS ONE"},{"issue":"15\u201316","key":"4861_CR121","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/hum.2020.053","volume":"31","author":"J Li","year":"2020","unstructured":"Li J, Li Y, Wang J, Gonzalez TJ, Asokan A, Napierala JS, et al. Defining transcription regulatory elements in the human frataxin gene: implications for gene therapy. Hum Gene Ther. 2020;31(15\u201316):839\u201351.","journal-title":"Hum Gene Ther"},{"issue":"23","key":"4861_CR122","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1093\/hmg\/ddaa267","volume":"29","author":"LN Rodden","year":"2021","unstructured":"Rodden LN, Chutake YK, Gilliam K, Lam C, Soragni E, Hauser L, et al. Methylated and unmethylated epialleles support variegated epigenetic Silencing in Friedreich ataxia. Hum Mol Genet. 2021;29(23):3818\u201329.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"4861_CR123","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s13311-019-00764-x","volume":"16","author":"JM Gottesfeld","year":"2019","unstructured":"Gottesfeld JM. Molecular mechanisms and therapeutics for the GAA.TTC expansion disease Friedreich ataxia. Neurotherapeutics. 2019;16(4):1032\u201349.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"4861_CR124","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ana.23698","volume":"72","author":"M Cnop","year":"2012","unstructured":"Cnop M, Igoillo-Esteve M, Rai M, Begu A, Serroukh Y, Depondt C, et al. Central role and mechanisms of beta-cell dysfunction and death in Friedreich ataxia-associated diabetes. Ann Neurol. 2012;72(6):971\u201382.","journal-title":"Ann Neurol"},{"key":"4861_CR125","doi-asserted-by":"publisher","first-page":"109828","DOI":"10.1016\/j.diabres.2022.109828","volume":"186","author":"J Tamaroff","year":"2022","unstructured":"Tamaroff J, DeDio A, Wade K, Wells M, Park C, Leavens K, et al. Friedreich\u2019s ataxia related diabetes: epidemiology and management practices. Diabetes Res Clin Pract. 2022;186:109828.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"4861_CR126","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13287-022-02977-y","volume":"13","author":"IBB Silva","year":"2022","unstructured":"Silva IBB, Kimura CH, Colantoni VP, Sogayar MC. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. Stem Cell Res Ther. 2022;13(1):309.","journal-title":"Stem Cell Res Ther"},{"key":"4861_CR127","doi-asserted-by":"publisher","first-page":"35145","DOI":"10.1038\/srep35145","volume":"6","author":"Y Kim","year":"2016","unstructured":"Kim Y, Kim H, Ko UH, Oh Y, Lim A, Sohn JW, et al. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo. Sci Rep. 2016;6:35145.","journal-title":"Sci Rep"},{"issue":"6","key":"4861_CR128","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1089\/scd.2016.0115","volume":"26","author":"W Wang","year":"2017","unstructured":"Wang W, Jin S, Ye K. Development of islet organoids from H9 human embryonic stem cells in biomimetic 3D scaffolds. Stem Cells Dev. 2017;26(6):394\u2013404.","journal-title":"Stem Cells Dev"},{"issue":"2","key":"4861_CR129","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","volume":"21","author":"GG Nair","year":"2019","unstructured":"Nair GG, Liu JS, Russ HA, Tran S, Saxton MS, Chen R, et al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells. Nat Cell Biol. 2019;21(2):263\u201374.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"4861_CR130","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.crmeth.2023.100466","volume":"3","author":"S Liang","year":"2023","unstructured":"Liang S, Zhao J, Baker RK, Tran E, Zhan L, Kieffer TJ. Differentiation of stem cell-derived pancreatic progenitors into insulin-secreting islet clusters in a multiwell-based static 3D culture system. Cell Rep Methods. 2023;3(5):100466.","journal-title":"Cell Rep Methods"},{"issue":"1","key":"4861_CR131","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41467-022-29646-1","volume":"13","author":"J Chmielowiec","year":"2022","unstructured":"Chmielowiec J, Szlachcic WJ, Yang D, Scavuzzo MA, Wamble K, Sarrion-Perdigones A, et al. Human pancreatic microenvironment promotes \u03b2-cell differentiation via non-canonical WNT5A\/JNK and BMP signaling. Nat Commun. 2022;13(1):1952.","journal-title":"Nat Commun"},{"issue":"8","key":"4861_CR132","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/acn3.51830","volume":"10","author":"LN Rodden","year":"2023","unstructured":"Rodden LN, McIntyre K, Keita M, Wells M, Park C, Profeta V, et al. Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia. Ann Clin Transl Neurol. 2023;10(8):1397\u2013406.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"4861_CR133","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/eye.2011.291","volume":"26","author":"S Noval","year":"2012","unstructured":"Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Ophthalmic features of Friedreich ataxia. Eye (Lond). 2012;26(2):315\u201320.","journal-title":"Eye (Lond)"},{"issue":"6","key":"4861_CR134","doi-asserted-by":"publisher","first-page":"111166","DOI":"10.1016\/j.celrep.2022.111166","volume":"40","author":"Y Sasamoto","year":"2022","unstructured":"Sasamoto Y, Lee CAA, Wilson BJ, Buerger F, Martin G, Mishra A, et al. Limbal BCAM expression identifies a proliferative progenitor population capable of holoclone formation and corneal differentiation. Cell Rep. 2022;40(6):111166.","journal-title":"Cell Rep"},{"issue":"1","key":"4861_CR135","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41536-023-00327-x","volume":"8","author":"D Agarwal","year":"2023","unstructured":"Agarwal D, Dash N, Mazo KW, Chopra M, Avila MP, Patel A, et al. Human retinal ganglion cell neurons generated by synchronous BMP Inhibition and transcription factor mediated reprogramming. NPJ Regen Med. 2023;8(1):55.","journal-title":"NPJ Regen Med"},{"issue":"8","key":"4861_CR136","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/stcltm\/szad039","volume":"12","author":"S Gupta","year":"2023","unstructured":"Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Sharma R, Faura G, et al. Progress in stem Cells-Based replacement therapy for retinal pigment epithelium: in vitro differentiation to in vivo delivery. Stem Cells Transl Med. 2023;12(8):536\u201352.","journal-title":"Stem Cells Transl Med"},{"issue":"25","key":"4861_CR137","doi-asserted-by":"publisher","first-page":"e2317285121","DOI":"10.1073\/pnas.2317285121","volume":"121","author":"J Harkin","year":"2024","unstructured":"Harkin J, Pena KH, Gomes C, Hernandez M, Lavekar SS, So K, et al. A highly reproducible and efficient method for retinal organoid differentiation from human pluripotent stem cells. Proc Natl Acad Sci U S A. 2024;121(25):e2317285121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4861_CR138","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41587-023-01747-2","volume":"41","author":"P Wahle","year":"2023","unstructured":"Wahle P, Brancati G, Harmel C, He Z, Gut G, Del Castillo JS, et al. Multimodal Spatiotemporal phenotyping of human retinal organoid development. Nat Biotechnol. 2023;41(12):1765\u201375.","journal-title":"Nat Biotechnol"},{"key":"4861_CR139","first-page":"141","volume":"4","author":"DE Crombie","year":"2015","unstructured":"Crombie DE, Van Bergen N, Davidson KC, Anjomani Virmouni S, McKelvie PA, Chrysostomou V, et al. Characterization of the retinal pigment epithelium in Friedreich ataxia. Biochem Biophys Rep. 2015;4:141\u20137.","journal-title":"Biochem Biophys Rep"},{"key":"4861_CR140","doi-asserted-by":"crossref","unstructured":"Koeppen AH, Mazurkiewicz JE. Friedreich Ataxia: Neuropathology Revised. 2013.","DOI":"10.1097\/NEN.0b013e31827e5762"},{"issue":"6","key":"4861_CR141","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s12311-024-01739-1","volume":"23","author":"ED Louis","year":"2024","unstructured":"Louis ED, Kuo SH, Faust PL. Purkinje cell dendritic swellings: A postmortem study of essential tremor and other cerebellar degenerative disorders. Cerebellum. 2024;23(6):2383\u201396.","journal-title":"Cerebellum"},{"issue":"8","key":"4861_CR142","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.ymthe.2018.05.006","volume":"26","author":"F Piguet","year":"2018","unstructured":"Piguet F, de Montigny C, Vaucamps N, Reutenauer L, Eisenmann A, Puccio H. Rapid and complete reversal of sensory ataxia by gene therapy in a novel model of Friedreich ataxia. Mol Ther. 2018;26(8):1940\u201352.","journal-title":"Mol Ther"},{"issue":"1\u20133","key":"4861_CR143","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","volume":"512","author":"CJ Miranda","year":"2002","unstructured":"Miranda CJ, Santos MM, Ohshima K, Smith J, Li L, Bunting M, et al. Frataxin knockin mouse. FEBS Lett. 2002;512(1\u20133):291\u20137.","journal-title":"FEBS Lett"},{"key":"4861_CR144","doi-asserted-by":"publisher","first-page":"e30054","DOI":"10.7554\/eLife.30054","volume":"6","author":"V Chandran","year":"2017","unstructured":"Chandran V, Gao K, Swarup V, Versano R, Dong H, Jordan MC, et al. Inducible and reversible phenotypes in a novel mouse model of friedreich\u2019s ataxia. Elife. 2017;6:e30054.","journal-title":"Elife"},{"issue":"2","key":"4861_CR145","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12311-025-01796-0","volume":"24","author":"DJ Joseph","year":"2025","unstructured":"Joseph DJ, Mercado-Ayon E, Flatley L, Viaene AN, Hordeaux J, Marsh ED, et al. Functional characterization of parallel Fiber-Purkinje cell synapses in two friedreich\u2019s ataxia mouse models. Cerebellum. 2025;24(2):42.","journal-title":"Cerebellum"},{"key":"4861_CR146","doi-asserted-by":"publisher","first-page":"115176","DOI":"10.1016\/j.expneurol.2025.115176","volume":"386","author":"E Mercado-Ayon","year":"2025","unstructured":"Mercado-Ayon E, Talgo E, Flatley L, Coulman J, Lynch DR. Neurochemical alterations in the cerebellum of friedreich\u2019s ataxia mouse models. Exp Neurol. 2025;386:115176.","journal-title":"Exp Neurol"},{"key":"4861_CR147","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neuroscience.2020.06.010","volume":"462","author":"ME van der Heijden","year":"2021","unstructured":"van der Heijden ME, Sillitoe RV. Interactions between purkinje cells and granule cells coordinate the development of functional cerebellar circuits. Neuroscience. 2021;462:4\u201321.","journal-title":"Neuroscience"},{"issue":"4","key":"4861_CR148","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12311-017-0913-2","volume":"17","author":"LM Watson","year":"2018","unstructured":"Watson LM, Wong MMK, Vowles J, Cowley SA, Becker EBE. A simplified method for generating purkinje cells from Human-Induced pluripotent stem cells. Cerebellum. 2018;17(4):419\u201327.","journal-title":"Cerebellum"},{"issue":"6","key":"4861_CR149","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41596-024-01093-w","volume":"20","author":"A Atamian","year":"2025","unstructured":"Atamian A, Birtele M, Hosseini N, Quadrato G. Generation and long-term culture of human cerebellar organoids from pluripotent stem cells. Nat Protoc. 2025;20(6):1584\u2013615.","journal-title":"Nat Protoc"},{"issue":"23\u201324","key":"4861_CR150","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1089\/hum.2020.264","volume":"31","author":"IH Harding","year":"2020","unstructured":"Harding IH, Lynch DR, Koeppen AH, Pandolfo M. Central nervous system therapeutic targets in Friedreich ataxia. Hum Gene Ther. 2020;31(23\u201324):1226\u201336.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"4861_CR151","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.26200","volume":"90","author":"IH Harding","year":"2021","unstructured":"Harding IH, Chopra S, Arrigoni F, Boesch S, Brunetti A, Cocozza S, et al. Brain structure and degeneration staging in Friedreich ataxia: magnetic resonance imaging volumetrics from the ENIGMA-Ataxia working group. Ann Neurol. 2021;90(4):570\u201383.","journal-title":"Ann Neurol"},{"issue":"1","key":"4861_CR152","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-016-0288-5","volume":"4","author":"AH Koeppen","year":"2016","unstructured":"Koeppen AH, Ramirez RL, Becker AB, Mazurkiewicz JE. Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation. Acta Neuropathol Commun. 2016;4(1):46.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4861_CR153","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/mds.28825","volume":"37","author":"W Khan","year":"2022","unstructured":"Khan W, Corben LA, Bilal H, Vivash L, Delatycki MB, Egan GF, et al. Neuroinflammation in the cerebellum and brainstem in Friedreich ataxia: an [18F]-FEMPA PET study. Mov Disord. 2022;37(1):218\u201324.","journal-title":"Mov Disord"},{"issue":"2","key":"4861_CR154","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.24846","volume":"81","author":"KC Kemp","year":"2017","unstructured":"Kemp KC, Cerminara N, Hares K, Redondo J, Cook AJ, Haynes HR, et al. Cytokine therapy-mediated neuroprotection in a friedreich\u2019s ataxia mouse model. Ann Neurol. 2017;81(2):212\u201326.","journal-title":"Ann Neurol"},{"key":"4861_CR155","doi-asserted-by":"publisher","first-page":"106631","DOI":"10.1016\/j.nbd.2024.106631","volume":"200","author":"A Vicente-Acosta","year":"2024","unstructured":"Vicente-Acosta A, Herranz-Martin S, Pazos MR, Galan-Cruz J, Amores M, Loria F, et al. Glial cell activation precedes neurodegeneration in the cerebellar cortex of the YG8-800 murine model of Friedreich ataxia. Neurobiol Dis. 2024;200:106631.","journal-title":"Neurobiol Dis"},{"key":"4861_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2014.12.017","volume":"76","author":"F Loria","year":"2015","unstructured":"Loria F, Diaz-Nido J. Frataxin knockdown in human astrocytes triggers cell death and the release of factors that cause neuronal toxicity. Neurobiol Dis. 2015;76:1\u201312.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4861_CR157","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12974-022-02442-w","volume":"19","author":"A Vicente-Acosta","year":"2022","unstructured":"Vicente-Acosta A, Gimenez-Cassina A, Diaz-Nido J, Loria F. The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes. J Neuroinflammation. 2022;19(1):93.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4861_CR158","doi-asserted-by":"publisher","first-page":"jcs263446","DOI":"10.1242\/jcs.263446","volume":"138","author":"C Marullo","year":"2025","unstructured":"Marullo C, Croci L, Giupponi I, Rivoletti C, Zuffetti S, Bettegazzi B, et al. Altered Ca2\u2009+\u2009responses and antioxidant properties in friedreich\u2019s ataxia-like cerebellar astrocytes. J Cell Sci. 2025;138(1):jcs263446.","journal-title":"J Cell Sci"},{"issue":"1","key":"4861_CR159","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1038\/s41598-022-16896-8","volume":"12","author":"BF Vahsen","year":"2022","unstructured":"Vahsen BF, Gray E, Candalija A, Cramb KML, Scaber J, Dafinca R, et al. Human iPSC co-culture model to investigate the interaction between microglia and motor neurons. Sci Rep. 2022;12(1):12606.","journal-title":"Sci Rep"},{"issue":"2","key":"4861_CR160","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Mu\u00f1oz JP, Richaud-Patin Y, et al. Patient-Specific iPSC-Derived astrocytes contribute to Non-Cell-Autonomous neurodegeneration in parkinson\u2019s disease. Stem Cell Rep. 2019;12(2):213\u201329.","journal-title":"Stem Cell Rep"},{"issue":"11","key":"4861_CR161","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.ymthe.2018.08.012","volume":"26","author":"S Yoshida","year":"2018","unstructured":"Yoshida S, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ohashi F, et al. Maturation of human induced pluripotent stem Cell-Derived cardiomyocytes by soluble factors from human mesenchymal stem cells. Mol Ther. 2018;26(11):2681\u201395.","journal-title":"Mol Ther"},{"issue":"15","key":"4861_CR162","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.cell.2022.06.051","volume":"185","author":"NS Corsini","year":"2022","unstructured":"Corsini NS, Knoblich JA. Human organoids: new strategies and methods for analyzing human development and disease. Cell. 2022;185(15):2756\u201369.","journal-title":"Cell"},{"issue":"1","key":"4861_CR163","doi-asserted-by":"publisher","first-page":"102379","DOI":"10.1016\/j.stemcr.2024.11.009","volume":"20","author":"SP Moss","year":"2025","unstructured":"Moss SP, Bakirci E, Feinberg AW. Engineering the 3D structure of organoids. Stem Cell Rep. 2025;20(1):102379.","journal-title":"Stem Cell Rep"},{"issue":"7","key":"4861_CR164","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.cell.2020.11.017","volume":"183","author":"J Andersen","year":"2020","unstructured":"Andersen J, Revah O, Miura Y, Thom N, Amin ND, Kelley KW, et al. Generation of functional human 3D Cortico-Motor assembloids. Cell. 2020;183(7):1913\u201329. e1926.","journal-title":"Cell"},{"issue":"6","key":"4861_CR165","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","volume":"31","author":"L Dao","year":"2024","unstructured":"Dao L, You Z, Lu L, Xu T, Sarkar AK, Zhu H, et al. Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell. 2024;31(6):818\u2013e833811.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4861_CR166","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.tibtech.2024.11.021","volume":"43","author":"L Kistemaker","year":"2025","unstructured":"Kistemaker L, van Bodegraven EJ, de Vries HE, Hol EM. Vascularized human brain organoids: current possibilities and prospects. Trends Biotechnol. 2025;43(6):1275\u201385.","journal-title":"Trends Biotechnol"},{"key":"4861_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20417314251319475","volume":"16","author":"X Fan","year":"2025","unstructured":"Fan X, Hou K, Liu G, Shi R, Wang W, Liang G. Strategies to overcome the limitations of current organoid technology - engineered organoids. J Tissue Eng. 2025;16:1\u201319.","journal-title":"J Tissue Eng"},{"issue":"1","key":"4861_CR168","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13287-019-1305-y","volume":"10","author":"AO Wong","year":"2019","unstructured":"Wong AO, Wong G, Shen M, Chow MZ, Tse WW, Gurung B, et al. Correlation between frataxin expression and contractility revealed by in vitro friedreich\u2019s ataxia cardiac tissue models engineered from human pluripotent stem cells. Stem Cell Res Ther. 2019;10(1):203.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4861_CR169","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00441-023-03821-2","volume":"394","author":"P Teli","year":"2023","unstructured":"Teli P, Kale V, Vaidya A. Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and Bioprinting. Cell Tissue Res. 2023;394(1):75\u201391.","journal-title":"Cell Tissue Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04861-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04861-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04861-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:02:21Z","timestamp":1770840141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04861-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":169,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4861"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04861-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}